Medivolve Inc
OTC:MEDVF

Watchlist Manager
Medivolve Inc Logo
Medivolve Inc
OTC:MEDVF
Watchlist
Price: 0.007 USD 16.67% Market Closed
Market Cap: 22.8m USD
Have any thoughts about
Medivolve Inc?
Write Note

Medivolve Inc
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medivolve Inc
Net Issuance of Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
Medivolve Inc
OTC:MEDVF
Net Issuance of Debt
-CA$332.4k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Andlauer Healthcare Group Inc
TSX:AND
Net Issuance of Debt
-CA$53m
CAGR 3-Years
-29%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
WELL Health Technologies Corp
TSX:WELL
Net Issuance of Debt
CA$37.9m
CAGR 3-Years
66%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
dentalcorp Holdings Ltd
TSX:DNTL
Net Issuance of Debt
-CA$40.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
KDA Group Inc
XTSX:KDA
Net Issuance of Debt
-CA$13.8m
CAGR 3-Years
-320%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
H
Healwell Al Inc
TSX:AIDX
Net Issuance of Debt
-CA$2.1m
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
N/A
No Stocks Found

Medivolve Inc
Glance View

Market Cap
22.8m USD
Industry
Health Care

Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-11-16. The firm is engaged in providing telehealth platform, a clinical diagnostic network, and a data driven artificial intelligence (AI) framework to improve patient care. The company offers a network of retail collection sites, which provides clinical services in diagnostic testing, vaccinations, and other point-of-care services. The company is also engaged in developing technologies to identify, treat, and prevent medical issues. The company provides solution in COVID-19 testing, immunity scoring, and vaccinations. Its COVID-19 Testing includes rapid antibody blood test, reverse transcription (RT)- polymerase chain reaction (PCR) test and antigen test. The firm uses channel partner Aditxt Therapeutics, Inc. (Aditxt) to offer COVID-19 immunity status monitoring through its mobile testing centers.

MEDVF Intrinsic Value
0.004 USD
Overvaluation 49%
Intrinsic Value
Price

See Also

What is Medivolve Inc's Net Issuance of Debt?
Net Issuance of Debt
-332.4k CAD

Based on the financial report for Dec 31, 2023, Medivolve Inc's Net Issuance of Debt amounts to -332.4k CAD.

What is Medivolve Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 1Y
82%

Over the last year, the Net Issuance of Debt growth was 82%.

Back to Top